Why Do GCA Patients Need Chest and Aortic Imaging?
At a Glance
Giant cell arteritis (GCA) can inflame the aorta, not just arteries in the head. Doctors order chest imaging, like CT or MRI scans, to detect silent inflammation and monitor for serious complications like aortic aneurysms. Early detection allows for safe management before emergencies occur.
In this answer
4 sections
It is very common for patients diagnosed with giant cell arteritis (GCA) to be confused when their doctor orders a CT scan or other imaging of the chest. Because GCA typically presents with severe headaches, jaw pain, and vision changes, it is often thought of as a disease that only affects the head (which is why it is sometimes called temporal arteritis). However, GCA is a systemic condition that can inflame the body’s largest arteries. Your doctor is ordering chest imaging because the inflammation caused by GCA can affect your aorta—the main artery carrying blood from your heart to the rest of your body—potentially leading to serious complications like an aortic aneurysm [1][2].
GCA is More Than a “Head Disease”
While the most visible and immediate threats of GCA involve the cranial arteries (such as the risk of permanent vision loss), the disease is classified as a “large-vessel vasculitis.” This means the immune system can attack any large artery in the body. Research shows that many patients with GCA also have inflammation in their extracranial (outside the head) arteries [1][2].
When GCA affects the aorta, it is known as aortitis (inflammation of the aorta) [3]. For many patients, this inflammation in the chest and large vessels causes no symptoms at all, meaning you could feel perfectly fine while your arteries are actively inflamed [1][4]. In some cases, large-vessel involvement might cause atypical symptoms like pain in the limbs when active (claudication) or lower back pain [5].
The Silent Risk of Aortic Aneurysm
Over time, chronic inflammation can weaken the structural walls of the aorta. This weakened wall can slowly balloon outward, creating an aortic aneurysm [6][7]. Patients with GCA have a significantly higher risk of developing an aortic aneurysm compared to the general population [8][9].
An aortic aneurysm is a serious, often “silent” condition. If an aneurysm grows too large without being treated, it can lead to life-threatening emergencies such as:
- Aortic dissection: A tear in the inner layer of the aorta’s wall [10].
- Aortic rupture: A complete break in the weakened blood vessel wall [9].
When to Seek Immediate Help: While most aneurysms are silent, a dissection or rupture is a medical emergency. If you ever experience sudden, severe, tearing or ripping pain in your chest or upper back, call 911 or seek emergency medical care immediately.
Because these structural changes can develop years after the initial GCA diagnosis—even when the disease appears to be in clinical remission and you feel healthy—routine monitoring is essential [3][11].
What if an aneurysm is found?
It is important to know that finding an early aneurysm is a good thing because it can be safely managed. Your care team will usually monitor it closely and prescribe medications to control your blood pressure, which reduces stress on the vessel wall. If the aneurysm grows too large, a planned surgery can repair it before it ever becomes an emergency.
Why Chest Imaging is Crucial
Since aortic inflammation and early aneurysms rarely cause symptoms, doctors rely on advanced imaging to see what is happening inside your blood vessels. Modalities like a CT scan (Computed Tomography), MRI (Magnetic Resonance Imaging), or a PET scan can detect inflammation and structural changes in the aorta [12][13]. Evaluating blood vessels for vasculitis typically requires intravenous (IV) contrast dye (used in CT angiography or MR angiography) to make the arteries clearly visible on the scan.
Getting a chest scan serves two main purposes:
- Establishing a Baseline: By scanning your chest soon after diagnosis, your doctor can see if there is any early thickening of the aortic wall or existing inflammation [14][15].
- Long-Term Monitoring: Because an aneurysm can take years to form, your care team may order follow-up scans periodically (often every 1 to 2 years, depending on your specific case) to ensure your aorta is maintaining its normal size and shape, allowing them to intervene early if an aneurysm starts to develop [16][17].
Risk Factors to Keep in Mind
While any GCA patient can develop aortic complications, certain factors might put you at a higher risk:
- Smoking: Current or past smoking is a strong risk factor for developing an aortic aneurysm [7][18].
- High Initial Inflammation: Patients who had particularly high levels of inflammation markers—like CRP or ESR (blood tests used to measure inflammation)—when they were first diagnosed may face a greater risk of future structural damage to the aorta [18].
- High Blood Pressure: High blood pressure (hypertension) adds physical stress to the aorta’s walls. Working with your doctor to manage your blood pressure is an excellent way you can actively help protect your blood vessels.
Common questions in this guide
Why do I need a chest CT if my GCA symptoms are in my head?
What is the risk of an aortic aneurysm with GCA?
Will I have symptoms if GCA affects my aorta?
How often do GCA patients need chest scans?
Does managing blood pressure help prevent GCA complications?
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.Did my baseline chest scans show any signs of aortic inflammation or thickening?
- 2.What type of imaging (CT, MRI, or PET) do you recommend for my long-term monitoring, and will it require contrast dye?
- 3.How frequently will we need to repeat chest imaging to monitor for an aortic aneurysm?
- 4.Are there any specific blood pressure targets I should aim for to reduce stress on my aorta?
- 5.Were my initial inflammatory markers (CRP and ESR) particularly high, and does that change my risk for large-vessel involvement?
Questions For You
Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.
Related questions
References
References (18)
- 1
French protocol for the diagnosis and management of giant cell arteritis.
de Boysson H, Devauchelle-Pensec V, Agard C, et al.
La Revue de medecine interne 2025; (46(1)):12-31 doi:10.1016/j.revmed.2024.10.011.
PMID: 39487062 - 2
Recent advances in the diagnosis and therapy of large vessel vasculitis.
Keser G, Atagunduz P, Soy M
Polish archives of internal medicine 2022; (132(6)) doi:10.20452/pamw.16272.
PMID: 35699647 - 3
Persistent aortic inflammation in patients with giant cell arteritis.
Kaymakci MS, Boire NA, Bois MC, et al.
Autoimmunity reviews 2023; (22(9)):103411 doi:10.1016/j.autrev.2023.103411.
PMID: 37597603 - 4
Atypical giant cell arteritis presentations diagnosed with FDG-18 whole body PET imaging.
Vijayaraghavan N, Martin J, Jayawickrama W, Otome O
BMJ case reports 2023; (16(1)) doi:10.1136/bcr-2022-251406.
PMID: 36631167 - 5
Comparative analysis of arterial involvement in predominant cranial and isolated extracranial phenotypes of giant cell arteritis using 18F-FDG PET-CT.
Narvaez J, Vidal-Montal P, Sánchez-Rodríguez I, et al.
Arthritis research & therapy 2024; (26(1)):230 doi:10.1186/s13075-024-03464-w.
PMID: 39732686 - 6
Large-vessel involvement and aortic dilation in giant-cell arteritis. A multicenter study of 549 patients.
de Boysson H, Daumas A, Vautier M, et al.
Autoimmunity reviews 2018; (17(4)):391-398 doi:10.1016/j.autrev.2017.11.029.
PMID: 29427822 - 7
Incidence and predictors of thoracic aortic damage in biopsy-proven giant cell arteritis.
Koster MJ, Crowson CS, Labarca C, Warrington KJ
Scandinavian journal of rheumatology 2021; (50(3)):239-242 doi:10.1080/03009742.2020.1786855.
PMID: 32940110 - 8
Aortic disease in giant cell arteritis.
Warrington KJ
Seminars in arthritis and rheumatism 2025; (72S()):152677 doi:10.1016/j.semarthrit.2025.152677.
PMID: 40021438 - 9
Will imaging change the diagnosis and management of giant cell arteritis?
Chiriac A, Badea C, Băicuș C
Romanian journal of internal medicine = Revue roumaine de medecine interne 2019; (57(4)):341-344.
PMID: 31120860 - 10
Repetitive aortic dissection in a patient with giant cell arteritis.
Motoji Y, Kurita J, Kawase Y, et al.
Asian cardiovascular & thoracic annals 2021; (29(2)):119-121 doi:10.1177/0218492320960866.
PMID: 32938203 - 11
Development of Giant Cell Arteritis after Treating Polymyalgia or Peripheral Arthritis: A Retrospective Case-control Study.
Liozon E, de Boysson H, Dalmay F, et al.
The Journal of rheumatology 2018; (45(5)):678-685 doi:10.3899/jrheum.170455.
PMID: 29545449 - 12
Imaging Findings in Giant Cell Arteritis: Don't Turn a Blind Eye to the Obvious!
Bathla G, Agarwal AK, Messina SA, et al.
AJNR. American journal of neuroradiology 2025; (46(3)):457-464 doi:10.3174/ajnr.A8388.
PMID: 38906672 - 13
Large vessel giant cell arteritis.
van der Geest KSM, Sandovici M, Bley TA, et al.
The Lancet. Rheumatology 2024; (6(6)):e397-e408 doi:10.1016/S2665-9913(23)00300-4.
PMID: 38574745 - 14
CT analysis of the aorta in giant-cell arteritis: a case-control study.
Berthod PE, Aho-Glélé S, Ornetti P, et al.
European radiology 2018; (28(9)):3676-3684 doi:10.1007/s00330-018-5311-8.
PMID: 29600479 - 15
Symptomatic aortitis at giant cell arteritis diagnosis: a prognostic factor of aortic event.
Espitia O, Blonz G, Urbanski G, et al.
Arthritis research & therapy 2021; (23(1)):14 doi:10.1186/s13075-020-02396-5.
PMID: 33413605 - 16
EULAR recommendations for the use of imaging in large vessel vasculitis in clinical practice: 2023 update.
Dejaco C, Ramiro S, Bond M, et al.
Annals of the rheumatic diseases 2024; (83(6)):741-751 doi:10.1136/ard-2023-224543.
PMID: 37550004 - 17
The utility of 18F-FDG-PET/CT in detecting extracranial large vessel vasculitis in rheumatic polymyalgia or giant cell arteritis. A systematic review and meta-analysis.
González-García A, Fabregate M, Serralta G, et al.
Revista clinica espanola 2024; (224(7)):445-456 doi:10.1016/j.rceng.2024.06.005.
PMID: 38852739 - 18
Evolution and outcomes of aortic dilations in giant cell arteritis.
Gallou S, Agard C, Dumont A, et al.
European journal of internal medicine 2024; (129()):71-77 doi:10.1016/j.ejim.2024.03.038.
PMID: 38580542
This page provides educational information about imaging and vascular monitoring for giant cell arteritis. It does not replace professional medical advice, so always consult your healthcare provider regarding your specific imaging needs and cardiovascular risk.
Get notified when new evidence is published on Giant cell arteritis.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.